Non-Small Cell Lung Carcinoma Suspected | TNM clinical staging
Item
suspected non-small cell lung cancer, stage ib, stage ii, or stage iiia
boolean
C0007131 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
Tumor size | Lesion size Equivalent
Item
tumor size > 3x3 cm or equivalent to a 9 cm² lesion
boolean
C0475440 (UMLS CUI [1])
C0449453 (UMLS CUI [2,1])
C0205163 (UMLS CUI [2,2])
Curative Surgery Planned
Item
scheduled surgery with curative intent
boolean
C1511562 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
must not be pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
agree to not receive any other investigative agent at any time while enrolled in this study
boolean
C0013230 (UMLS CUI [1])
Prior Therapy Non-Small Cell Lung Carcinoma
Item
previous treatment for non-small cell lung cancer
boolean
C1514463 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Sign or Symptom Clinical
Item
clinical signs or symptoms of brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C3540840 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Immunosuppression | Autoimmune Disease
Item
history of immune suppression or autoimmune disorder
boolean
C4048329 (UMLS CUI [1])
C0004364 (UMLS CUI [2])
Communicable Disease Severe Preventing Clinical Trial Completion | Illness Serious Preventing Clinical Trial Completion
Item
severe active infection or other serious medical illness, that in the opinion of the principal investigator, would prevent study completion
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0205197 (UMLS CUI [1,5])
C0221423 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0205197 (UMLS CUI [2,5])
Malignant Neoplasms | Carcinoma in situ of uterine cervix Treated | Skin carcinoma Treated
Item
other malignancies in the past 5 years, except adequately treated in situ cervix carcinoma or non-melanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0699893 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])